New insights into plant growth

Asymmetric distribution of brassinosteroids after mitotic cell division

Ghent, Belgium, 17 April 2025 – New research from an international team of plant biologists, led by researchers at the VIB-UGent Center for Plant Systems Biology, has revealed crucial insights into the role brassinosteroids – essential plant hormones – play in regulating cell division and growth. The findings, published in Cell, provide a comprehensive understanding of how these hormones influence development at the cellular level.

Plants on steroids

Brassinosteroids are vital hormones for plants, which influence their growth and development at the cellular level. Understanding the dynamics of brassinosteroid signaling helps us grasp how plants grow, adapt to their surroundings, and manage resources effectively. This knowledge could pave the way for improving crop growth and resilience in a rapidly changing environment.

New research led by Prof. Jenny Russinova (VIB-UGent) in close collaboration with late Philip Benfey’s lab (Duke University) and later work led by Prof. Trevor Nolan (California Institute of Technology), explores the dynamics of key brassinosteroid signaling components in the root meristem. The study reveals that following symmetric anticlinal divisions, these components are distributed unevenly, leading to the preferential expression of brassinosteroid biosynthetic enzymes the lower daughter cell post-division. This asymmetric hormonal signaling is essential for root growth and development in plants.

“We found,” says Dr. Nemanja Vukašinović, co-first author of the study, “that during cell division, brassinosteroids are distributed unevenly between the new cells formed. This means that one cell receives a boost in hormone activity, while the other supports the production of the hormones.”

Nemanja Vukašinović and Jenny Russinova

Tracking plant hormones

Using an innovative combination of single-cell RNA sequencing and long-term live-cell imaging, the team traced fluctuations in brassinosteroid signaling across different phases of the cell cycle. They discovered that signaling peaks during the G1 phase and diminishes during mitosis, highlighting a crucial time window for hormonal action in plant cell development. This phase-dependent regulation may influence how plants adapt to their environment and optimize their growth.

“Understanding how brassinosteroid signaling operates in relation to the cell cycle opens new avenues to manipulate plant growth and development,” said Prof. Russinova. “Our research not only sheds light on fundamental biological processes but also sets the stage for biotechnological applications in crop improvement.”

The study also raises important questions about the mechanisms regulating this uneven distribution and its consequences for overall plant health and functioning. That knowledge, in turn, holds promise for future agricultural strategies, especially as global food demands increase.


Data availability:

The scRNA-seq datasets used in this study can be accessed via the interactive browser here: https://nolanlab.shinyapps.io/arvex.

 

Publication

Polarity-guided uneven mitotic divisions control brassinosteroid activity in proliferating plant root cells. Vukašinović, Hsu, et al. Cell, 2025.

 

Funding

This work was supported by FWO, EMBO, Howard Hughes Medical Institute, the University of California, The California Institute of Technology, ERC, the National Natural Science Foundation of China, NIH, and NSF.


Gunnar De Winter

Gunnar De Winter

Science Communications Expert, VIB

 

Share

Latest stories

Website preview
Blocking lipid production in healthy lung cells can reduce lung metastasis
Leuven, 17 March 2026 - Scientists from the VIB–KU Leuven Center for Cancer Biology, in collaboration with the Francis Crick Institute, have discovered how cancer cells can exploit healthy lung cells to support metastatic tumor growth in the lungs. In two complementary studies published in Nature Cell Biology and Cancer Discovery, they show that tumors use lipids produced by lung cells as signals, and that decreasing the lipid production of lung cells can decrease metastasis. The findings point to new therapeutic strategies that target lung cell lipid production, rather than cancer cells themselves, which may also help refine patient selection for ongoing clinical trials targeting this pathway.
press.vib.be
Website preview
Researchers identify major genetic risk factor for rare form of dementia
Antwerp, 12 March 2026 - Researchers at VIB and Antwerp University have identified a major genetic risk factor for a rare form of frontotemporal dementia. The discovery, published today in Nature Genetics, provides a biological entry point for a disease subtype that has been difficult to study. It could not only help to improve diagnosis and patient stratification, but also opens up new avenues toward targeted treatments.
press.vib.be
Website preview
Protealis Announces Regulatory Approval of its First Biological Solution MagNfixTM and Launch of Five New Soybean Varieties
Ghent (Belgium), 11 March 2026 – Protealis, the European specialist in non-GMO legume seeds and seed technologies, today announces several milestones that significantly strengthen its position in a fast-growing European soybean market. The company has obtained European regulatory approval from EFCI1 (EU Fertilising Products Regulation (FPR) 2019/1009) for MagNfix™, its first biological solution, which is a proprietary soybean inoculant seed coating that is designed to support higher soybean yield and protein content. In addition, Protealis has secured the registration of five new soybean varieties across four European countries. This includes the introduction of two new maturity group (MG) 000 soybean varieties in Poland, the registration of its first maturity group 0000 ultra-early soybean variety in France, and a new soy variety registration for Belgium. In Germany, Protealis received registration for its second 00 MG soybean variety suited for the regions in southern Germany...
press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be